Tolerance Bio will increase health span by preserving, restoring, and manipulating the function of the thymus, the master regulator of immune tolerance

Gradient background with abstract geometric design

News & UPDATES

Featured
Tolerance Bio Licenses Clinical-Stage Long-Acting Interleukin-7 Therapy Efineptakin Alfa from NeoImmuneTech to Advance Programs Targeting Thymic Function and Immune Resilience
Read more →
Tolerance Bio’s Implanted iPSC-derived Thymic Organoids Enable In Vivo Positive Selection of Human T cells and Tumor Burden Reduction in Melanoma 
Read more →
Tolerance Bio and ZipCode Bio Announce Strategic R&D Collaboration to Advance Targeted Thymus Therapeutics 
Read more →